Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1012

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 3
Chunk 1012
---
 2025
  
    Sang Hoon Kim

    /s/ Gihyoun Bang
     
    Chief Financial Officer
     
    April 22, 2025
  
    Gihyoun Bang
     
     (Principal Financial Officer)

    /s/ Constance Höfer
     
    Chief Scientific Officer
     
    April 22, 2025
  
    Constance Höfer

    /s/ Phil Geon Lee
     
    Director
     
    April 22, 2025
  
    Phil Geon Lee

    /s/ Alcide Barberis
     
    Director
     
    April 22, 2025
  
    Alcide Barberis

    /s/ Seng Chin Mah
     
    Director
     
    April 22, 2025
  
    Seng Chin Mah

    /s/ Jin Whan Park
     
    Director
     
    April 22, 2025
  
    Jin Whan Park

    /s/ Sang Hyun Kim
     
    Director
     
    April 22, 2025
  
    Sang Hyun Kim

    /s/ Hyuk Joo Jee
     
    Director
     
    April 22, 2025
  
    Hyuk Joo Jee

    /s/ Joong Myung Cho
     
    Director
     
    April 22, 2025
  
    Joong Myung Cho

115

OSR HOLDINGS, INC.

(f/k/a Bellevue Life
Sciences Acquisition Corp.)

INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS 

    Page
  
    Report of Independent Registered Public Accounting Firm (PCAOB ID #100) 
    F-2
  
    Consolidated Financial Statements:

    Consolidated Balance Sheets as of
    December  31, 2024 and 2023
    F-3
  
    Consolidated Statements of
    Operations for the years ended December 31, 2024 and 2023
    F-4
  
    Consolidated Statements of Changes
    in Stockholders’ Deficit for the years ended December 31, 2024 and 2023
    F-5
  
    Consolidated Statements of Cash
    Flows for the years ended December 31, 2024 and 2023
    F-6
  
    Notes to Consolidated Financial
    Statements
    F-7